CA
NZ
UK
AU
IND
US
Director Laura J. Schumacher filed a Form 4 with the SEC on September 18, 2026, disclosing the acquisition of 105 shares of General Dynamics Corp common stock on September 16, 2026, received in lieu of director fees under the company's outside directors' compensation program.
Director John G. Stratton filed a Form 4 with the SEC on September 18, 2026, reporting the acquisition of General Dynamics Corp (NYSE:GD) common stock on September 16, 2026, received in lieu of director fees.
David Lawrence Thompson Jr., a director and officer of American Financial Group Inc, filed a Form 4 on September 18, 2026, disclosing two acquisitions of common stock on September 16, 2026, both resulting from a pro rata distribution of shares held by Seraphim Partners …
Ellie Eunkyung Im, Chief Medical Officer of Crescent Biopharma, Inc. (NASDAQ:CBIO), filed a Form 4 on September 18, 2026, reporting the automatic sale of 623 ordinary shares on September 16, 2026, to satisfy tax withholding obligations tied to vesting restricted stock units.
Jan Pinkas, Chief Scientific Officer of Crescent Biopharma, Inc., filed a Form 4 on September 18, 2026, reporting the automatic sale of 658 ordinary shares on September 16, 2026, to satisfy tax withholding obligations tied to the vesting of restricted stock units.
Ryan Lynch, Treasurer, Senior Vice President of Finance and Chief Accounting Officer of Crescent BioPharma, Inc. (NASDAQ:CBIO), filed a Form 4 on September 18, 2026, disclosing an automatic sale of ordinary shares on September 16, 2026, to satisfy tax withholding obligations tied to vesting …
Joelle M. Smith, President of First Advantage Corp, filed a Form 4 on September 18, 2026, reporting transactions in common stock and restricted stock units dated September 16, 2026, on the NASDAQ exchange under ticker NASDAQ:FA.
KKR Alternative Assets LLC filed a Form 4 on September 18, 2026, disclosing that it contributed 1,933,109 Class I shares of KKR Real Estate Select Trust Inc. common stock to the issuer for no consideration, with the shares to be permanently cancelled.
Daniel Schumacher, Chief Financial Officer of Proto Labs Inc (NYSE:PRLB), filed a Form 4 on September 18, 2026, disclosing the sale of 5,000 shares of common stock across two transactions on September 16 and September 17, 2026, executed under a pre-established Rule 10b5-1 trading …
William L. Simmons, Group Executive for FMT and FSDP at IDEX Corp, filed a statement of changes in beneficial ownership with the SEC on September 18, 2026, disclosing a transaction in IDEX Corp common stock dated September 16, 2026.
Please wait processing your request...